resTORbio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of aging-related diseases primarily in the United States.
Full Time Employees: 21
Founded in 2016
Headquartered in Boston, Massachusetts
http://www.restorbio.com
Valuation at IPO $410M
Amount Raised $85M
No comments:
Post a Comment